|
Hepcidin expression in iron overload diseases is variably modulated by circulating factors.
PLoS One. 2012;7(5):e36425
Authors: Ravasi G, Pelucchi S, Trombini P, Mariani R, Tomosugi N, Modignani GL, Pozzi M, Nemeth E, Ganz T, Hayashi H, Barisani D, Piperno A
Abstract
Hepcidin is a regulatory hormone that plays a... |
|
Read more...
|
|
|
Late stage erythroid precursor production is impaired in mice with chronic inflammation.
Haematologica. 2012 May 11;
Authors: Prince OD, Langdon JM, Layman AJ, Prince IC, Sabogal M, Mak HH, Berger AE, Cheadle C, Chrest FJ, Yu Q, Andrews NC, Xue QL, Civin CI, Walston JD, Roy CN
Abstract
Background: We and others... |
|
Read more...
|
|
Erythropoietin-driven signaling ameliorates the survival defect of DMT1-mutant erythroid progenitors and erythroblasts.
Haematologica. 2012 May 11;
Authors: Horvathova M, Kapralova K, Zidova Z, Dolezal D, Pospisilova D, Divoky V
Abstract
Background. Hypochromic microcytic anemia associated with ineffective... |
|
Read more...
|
|
|
Miiuy croaker hepcidin gene and comparative analyses reveal evidence for positive selection.
PLoS One. 2012;7(4):e35449
Authors: Xu T, Sun Y, Shi G, Wang R
Abstract
Hepcidin antimicrobial peptide (HAMP) is a small cysteine-rich peptide and a key molecule of the innate immune system against bacterial infections.... |
|
Read more...
|
|
A Case of Congenital Dyserythropoietic Anemia Type 1 in a Japanese Adult with a CDAN1 Gene Mutation and an Inappropriately Low Serum Hepcidin-25 Level.
Intern Med. 2012;51(8):917-20
Authors: Kawabata H, Doisaki S, Okamoto A, Uchiyama T, Sakamoto S, Hama A, Hosoda K, Fujikura J, Kanno H, Fujii H, Tomosugi N, Nakao K, Kojima S,... |
|
Read more...
|
|
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
|
Page 1 of 25 |
